Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma
Rami Rahal(Novartis (Switzerland)), Mareike Frick(Charité - Universitätsmedizin Berlin), Rodrigo Romero(Novartis (United States)), Joshua M. Korn(Novartis (United States)), Robert Kridel(BC Cancer Agency), Fong Chun Chan(BC Cancer Agency), Barbara Meissner(BC Cancer Agency), Hyo-Eun Carrie Bhang(Novartis (United States)), Dave Ruddy(Novartis (United States)), Audrey Kauffmann(Novartis (Switzerland)), Ali Farsidjani(Novartis (United States)), Adnan Derti(Novartis (United States)), Daniel P. Rakiec(Novartis (United States)), Tara L. Naylor(Novartis (United States)), Estelle Pfister(Novartis (Switzerland)), Steve G. Kovats(Novartis (United States)), Sunkyu Kim(Novartis (United States)), Kerstin Dietze(Charité - Universitätsmedizin Berlin), Bernd Dörken(Charité - Universitätsmedizin Berlin), Christian Steidl(BC Cancer Agency), Alexandar Tzankov(University Hospital of Basel), Michael Hummel(Charité - Universitätsmedizin Berlin), John E. Monahan(Novartis (United States)), Michael Morrissey(Novartis (United States)), Christine Fritsch(Novartis (Switzerland)), William R. Sellers(Novartis (United States)), Vesselina G. Cooke(Novartis (United States)), Randy D. Gascoyne(BC Cancer Agency), Georg Lenz(Charité - Universitätsmedizin Berlin), Frank Stegmeier(Novartis (Switzerland))
Cited by 331
Abstract
Related Papers
No related papers found
Powered by citation graph analysis